IBEX Limited

NASDAQ:IBEX

29.91 (USD) • At close July 16, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42018 Q22018 Q12017 Q22017 Q1
Revenue 140.736140.682129.717124.531126.795132.634124.609124.431131.596139.39127.876123.70720.535132.184108.573108.878108.832117.181108.771100.88101.124107.78495.34787.91594.37789.38778.78187.492
Cost of Revenue 96.01798.76290.04185.37387.08395.88488.19687.35698.22499.7996.15398.373101.279103.79379.62984.19672.38678.9672.26469.00968.00673.18566.05563.09852.9674.98834.16666.512
Gross Profit 44.71941.9239.67639.15839.71236.7536.41337.07533.37239.631.72325.334-80.74428.39128.94424.68236.44638.22136.50731.87133.11834.59929.29224.81741.41714.39944.61520.98
Gross Profit Ratio 0.3180.2980.3060.3140.3130.2770.2920.2980.2540.2840.2480.205-3.9320.2150.2670.2270.3350.3260.3360.3160.3270.3210.3070.2820.4390.1610.5660.24
Reseach & Development Expenses 0000000000000000000000000000
General & Administrative Expenses 0000000268.88786.70193.98588.20185.97789.58191.63576.79773.70673.68479.57774.35369.48767.79473.23666.09774.19297.56184.04180.24974.359
Selling & Marketing Expenses 0000000-8.4862.8232.4793.1843.0843.1433.4893.1922.9733.2753.3994.1023.7244.2784.5054.8214.8390000
SG&A 27.06125.70626.21521.68123.56524.85723.0423.71789.52496.46491.38589.06192.72495.12479.98976.67976.95982.97678.45573.21172.07277.74170.91879.03197.56184.04180.24974.359
Other Expenses 4.3294.2864.3694.6084.865100.8393.2380.09227.46629.9427.06127.26727.11829.13227.118-42.837027.87125.03614.255022.4321.26111.0836.23410.4236.2349.429
Operating Expenses 31.3929.99230.58426.28928.4329.80328.08228.769116.99126.404118.446116.328119.842124.256105.656103.35101.995110.847109.684101.61493.333100.17190.75490.114103.79594.46486.48383.788
Operating Income 13.32911.9289.09212.86911.2826.9478.3318.30615.38312.9867.2656.0819.26612.1155.7175.9742.4046.334-0.913-0.7348.0417.6134.593-2.277-8.542-4.973-7.2023.704
Operating Income Ratio 0.0950.0850.070.1030.0890.0520.0670.0670.1170.0930.0570.0490.4510.0920.0530.0550.0220.054-0.008-0.0070.080.0710.048-0.026-0.091-0.056-0.0910.042
Total Other Income Expenses Net -0.372-0.3090.4210.3670.3070.4010.482-3.4990.556-0.162-0.1-2.202-5.554-2.31-2.11-2.111-2.31-2.374-2.239-2.238-2.376-2.507-2.307-2.251-1.258-1.254-1.454-1.403
Income Before Tax 12.95711.6199.51313.23611.5897.3488.8138.31613.6073.935.3963.8793.7129.8053.6073.8630.0943.96-3.152-2.9725.6655.1062.286-4.528-9.8-6.227-8.6562.301
Income Before Tax Ratio 0.0920.0830.0730.1060.0910.0550.0710.0670.1030.0280.0420.0310.1810.0740.0330.0350.0010.034-0.029-0.0290.0560.0470.024-0.052-0.104-0.07-0.110.026
Income Tax Expense 2.4882.3511.9823.3911.2791.2731.3883.8061.9072.0651.09-1.034-2.8861.340.593-0.1640.3391.4720.2710.8331.1830.349-0.050.119-0.149-1.419-0.11-0.445
Net Income 10.4699.2687.5319.84510.316.0757.42513.71111.2791.8654.3064.9136.5988.4653.0144.027-0.2452.488-3.423-3.8054.4824.7572.336-0.248-9.651-4.808-7.6942.746
Net Income Ratio 0.0740.0660.0580.0790.0810.0460.060.110.0860.0130.0340.040.3210.0640.0280.037-0.0020.021-0.031-0.0380.0440.0440.024-0.003-0.102-0.054-0.0980.031
EPS 0.790.610.450.570.590.340.410.250.640.10.240.270.360.460.170.22-0.0140.14-0.21-0.220.250.310.15-0.014-0.55-0.27-0.430.16
EPS Diluted 0.730.570.430.560.570.330.390.240.610.0990.230.260.350.450.160.21-0.0140.13-0.21-0.220.250.310.15-0.014-0.55-0.27-0.430.16
EBITDA 17.6916.52514.04418.01916.57812.40513.95913.35823.30621.74115.959.82617.82116.59710.5613.56614.09513.3175.5265.27814.13814.02610.2932.764-5.352-1.764-3.757.095
EBITDA Ratio 0.1260.1170.1080.1450.1310.0940.1120.1070.1770.1560.1250.0790.8680.1260.0970.1250.130.1140.0510.0520.140.130.1080.031-0.057-0.02-0.0480.081